Company intelligence / Profile preview

HAPPE Spine

Holland, Michigan, United States

Ownership: Private
Development stage: Other

Overview

Clinical use of the INTEGRATE-C™ Interbody Fusion System demonstrated excellent handling, immediate blood/factor wicking, and radiographic bone integration; more than 1,000 patients have benefited, with accelerated healing reported by surgeons in less than half the time versus current standards[3][5].

Therapeutic areas: OtherRheumatology
Modalities: DeviceHydrogel-based drug delivery therapyBiologic (bone-interactive biomaterial)
Industry: Implantable Medical Devices

Partnerships

cultivate(MD) Capital Funds (investor/strategic partner)[1][4]

Beyond the preview

Go deeper on HAPPE Spine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HAPPE Spine.

Explore the full profile